SGHT Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
23.4M
+18.7%
19.7M
-3.4%
20.4M
+2.4%
19.9M
+1.7%
19.6M
Cost of Revenue
2.0M
-26.0%
2.7M
+4.7%
2.6M
-4.1%
2.7M
-9.0%
3.0M
Gross Profit
21.4M
+25.9%
17.0M
-4.6%
17.8M
+3.4%
17.2M
+3.7%
16.6M
Operating Expenses
25.3M
-14.0%
29.4M
+37.0%
21.5M
-14.5%
25.1M
-11.2%
28.3M
R&D
2.5M
-1.3%
2.5M
+4.5%
2.4M
-27.3%
3.4M
-23.6%
4.4M
SG&A
22.8M
-15.3%
26.8M
+41.1%
19.0M
-12.6%
21.8M
-8.9%
23.9M
Operating Income
-3888000
+68.7%
-12413000
-238.3%
-3669000
+53.6%
-7905000
+32.2%
-11667000
EBITDA
-3794000
+69.2%
-12310000
-245.7%
-3561000
+54.3%
-7800000
+32.4%
-11542000
Net Income
-4446000
+65.7%
-12980000
-211.9%
-4162000
+49.1%
-8169000
+31.6%
-11941000
EPS (Basic)
$-0.08
+66.7%
$-0.24
-200.0%
$-0.08
+50.0%
$-0.16
+30.4%
$-0.23
EPS (Diluted)
$-0.08
+66.7%
$-0.24
-200.0%
$-0.08
+50.0%
$-0.16
+30.4%
$-0.23
Shares (Diluted)
54.5M
+1.0%
53.9M
+1.6%
53.1M
+1.4%
52.4M
+1.1%
51.8M
Sight Sciences (SGHT) โ€” Financials